Douglas Aircraft Co. v. Mueller

194 F. Supp. 268, 130 U.S.P.Q. (BNA) 426, 1961 U.S. Dist. LEXIS 6010
CourtDistrict Court, District of Columbia
DecidedApril 25, 1961
DocketCiv. A. No. 905-57
StatusPublished

This text of 194 F. Supp. 268 (Douglas Aircraft Co. v. Mueller) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Douglas Aircraft Co. v. Mueller, 194 F. Supp. 268, 130 U.S.P.Q. (BNA) 426, 1961 U.S. Dist. LEXIS 6010 (D.D.C. 1961).

Opinion

SIRICA, District Judge.

Plaintiffs filed an action under 35 U.S. C.A. § 145 seeking a judgment from this Court entitling them to receive a patent on their application, Serial No. 316,325 of October 22,1952 entitled “Phosphonate Ester Hydraulic Fluid” for use in the hydraulic systems of aircraft operating at the low temperatures of high altitudes. A prior patent, issued to one Watson, also concerning an aircraft hydraulic fluid composition, taught that a mixture of dioctyl styrene phosphonate when combined with certain polymerized methacrylic acid esters (viscosity index-improving agents) produced the desired fluid viscosity at the desired low temperature. Plaintiff Moreton’s suggested composition contained a dibutyl phenyl phosphonate and possessed admitted novelty.

The issue at trial was whether plaintiffs’ composition, in the light of the prior Watson patent, met the statutory test of not being obvious to one having ordinary skill in the prior art. At trial, since plaintiffs were claiming unexpected results over a prior patent, it was necessary for them to show comparative tests between the application and the reference. Plaintiffs established that two isomers of the Watson patent were inoperative at the required low temperature (-40°F.). After trial, in their post-trial brief, the Patent Office urged that there was a third isomer of Watson’s dioctyl styrene phosphonate, called di-n-octyl styrene phosphonate, and that since plaintiffs had failed to test and show the inoperativeness of this third isomer, they had failed to sustain their burden of proof. Plaintiffs’ request to reopen the record to rebut this argument was denied by this Court, and judgment was entered for the defendants.1

On appeal, the United States Court of Appeals for the District of Columbia Circuit in its remand of the case,2 commented on that denial as follows:

“We think this was error in all the circumstances, especially considering the fact that with the use of the two isomers as to which there was test evidence, Watson was found inoperative. When, after trial, the third isomer came on the scene, not by evidence but by briefs, the right to introduce evidence on the subject should have been granted if, as was the case, the decision might have been different if the new evidence should also support the claim of Moretón that Watson was inoperative. In that event the unexpected result achieved by Moreton, though within the general area of Watson, might well be found to have been a combination not obvious to one ordinarily skilled in the prior art, and this, with admitted novelty, ^vould entitle him [270]*270to a successful outcome of Ms action in the District Court.” 107 U.S.App. D.C. at page 324, 277 F.2d at page 354. (Emphasis added.)

By order of February 27, 1961, this Court scheduled a re-hearing of the case, limited to the question of whether or not the third isomer, di-n-octyl styrene phosphonate, was inoperative. At the hearing, the Court, after referring to the language cited above from the opinion of the Court of Appeals, asked counsel the following question:

« * * * in view of the language I have just quoted from the opinion of the Court of Appeals, do the plaintiff and defendant agree, that if it is shown that this third isomer, di-normal-octyl styryl phosphonate, is also inoperative, then the Court should decide that plaintiff’s composition is the production of unusual and unexpected results, and therefore find for the plaintiff?” (Transcript, p. 4.)

Counsel for plaintiffs replied as follows:

“Mr. Browne: May it please Your Honor, I agree that if inoperativeness is established by the evidence we produce this morning, we are undeniably entitled to receive the patent.” (Transcript, p. 4.)

Counsel for defendants replied as follows :

“Mr. Moore: * * * I agree that if the plaintiffs prove inoperativeness of that specific compound, di-noctyl styryl phosphonate they would be within the purview of the Court of Appeals decision, for Your Honor to authorize the issuance of a patent.” (Transcript, p. 5.)

At the rehearing on this limited issue, plaintiffs called two witnesses. Plaintiffs’ witness Sidney M. Collegeman, an employee of the Bureau of Naval Weapons, testified as to the required standards of viscosity of aircraft hydraulic fluids at -40 degrees F. Plaintiffs’ witness Christian A. Seil, Chief of the Non-Metallic Section of Materials Research and Process Engineering of the Santa Monica Division of plaintiff Douglas Aircraft Company, testified concerning the preparation and testing of the third isomer, di-n-oetyl styryl phosphonate.

Government counsel offered no evidence in rebuttal and did not cross-examine the witness Collegeman, but relied solely on his cross-examination of the witness Seil.

After considering the evidence offered by plaintiff at the rehearing and the cross-examination of the witness Seil, the Court is of the opinion that plaintiffs have established inoperativeness of the third isomer. Though this is a trial de novo, (Cf., American Steel & Wire Co. of New Jersey v. Coe, 1939, 70 App.D.C. 138, 105 F.2d 17), the defendants, who have access to the largest laboratory facilities in the nation, did not offer any evidence to rebut plaintiffs’ evidence of inoperativeness.

After a reconsideration of the entire record of the prior hearing, and after considering the evidence of plaintiffs at the rehearing, the Court feels that if it had had this evidence of the inoperativeness of the third isomer before it at the original hearing, it might have reached a result in favor of the plaintiffs. Considering the entire record, the opinion of the Court of Appeals, plaintiffs’ evidence on rehearing and the total failure of the defendants to offer any evidence in rebuttal, the Court finds that the difference between plaintiffs’ composition and the prior Watson art is such that the subject matter as a whole would not have been obvious at the time the invention was made to a person having ordinary skill in the art to which the subject matter pertains. The Court finds that the plaintiffs are entitled to receive a patent containing claims 3, 4, 5, 7 and 8, as set forth in Douglas H. Moreton Application Serial No. 316,325, filed October 22, 1952, and the Commissioner of Patents is hereby authorized to issue such a patent. Cf. Stradar v. Watson, 1957, 100 U.S. App.D.C. 289, 244 F.2d 737.

Accordingly, the Court makes the following Findings of Fact and Conclusions of Law:

Findings of Fact

1. Douglas H. Moreton, applicant for patent, and his assignee, Douglas Air[271]*271craft Company, Inc., brought this action under 35 U.S.C. § 145, to authorize the Commissioner of Patents to issue Letters Patent to them containing claims 3, 4, 5, 7 and 8 of the application for patent of Douglas H. Moreton entitled, “Phosphonate Ester Hydraulic Fluid,” Serial No. 316,325, filed October 22, 1952.

2. Generic claim 8, and claims 3, 4, 5 and 7, dependent thereon, in suit, read as follows:

“8.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
194 F. Supp. 268, 130 U.S.P.Q. (BNA) 426, 1961 U.S. Dist. LEXIS 6010, Counsel Stack Legal Research, https://law.counselstack.com/opinion/douglas-aircraft-co-v-mueller-dcd-1961.